|
Market Cap (5-Jun) $4,172,944 (725th) |
Close (30-Jun) $0.260 |
Volume (30-Jun) 239,872 |
Shortsold (5-Oct) 64,772 (0.03%) (542nd) |
|
52w High $0.043 |
52w Low $0.012 |
P/E 11.29 |
EPS -0.06 |
UBI released this announcement to the ASX on 24 December 2021, 9:11. The announcement is marked as price sensitive, and is 5 page(s) in length and 425.13kb in size.
You can view all announcements from UBI and see how they appear on a price chart on the announcements page.
At the date of this announcement, UBI was 0.008% short sold according to ASIC data. It was ranked the 639th most shorted stock on the ASX. It is now ranked as the 542nd most shorted stock on the ASX with 0.030% of total shares short sold as of the latest reported data (05 October 2023).
| Other Recent Announcements from UBI | |
|---|---|
| Results of 2023 Annual General meeting | 22 May 2023, 12:14 |
| CEO's AGM address to Securityholders | 22 May 2023, 8:33 |
| Q1 2023 Results | 11 May 2023, 15:41 |
| UBI signs deal to commercialise SARS-CoV-2 N-Protein Test | 24 December 2021, 9:11 |
| Application for quotation of securities - UBI | 17 December 2021, 16:17 |
| Application for quotation of securities - UBI | 17 December 2021, 16:15 |
| Notification of cessation of securities - UBI | 17 December 2021, 16:13 |
You must be logged in to post a reply.
Universal Biosensors, Inc 